Literature DB >> 16188399

Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.

Cecilia Sepúlveda1, Rodrigo Prado.   

Abstract

OBJECTIVE: To demonstrate that an effective cervical cancer screening programme based on the Papanicolaou (Pap) smear can be organized in a middle-income country, such as Chile.
METHODS: The cervical cytology screening programme in Chile is evaluated by comparing process measures and cervical cancer mortality before and after its reorganization in 1987.
FINDINGS: Two decades of opportunistic annual screening for cervical cancer from the mid-1960s to the mid-1980s did not reduce cervical cancer mortality in Chile. In 1987, a public health oriented program was launched, based on screening women aged 25-64 every 3 years, rather than the annual screening of low risk women attending family planning clinics that gathered mainly women less than 25 years of age. The reoriented program emphasized the optimization of existing resources, the timeliness of diagnosis and treatment, reliability of the Pap smear and low cost screening promotion strategies at the community level. More than 80% of women with abnormal Pap smears received prompt medical attention and 100% of the public laboratories were subject to external quality control. According to biannual national surveys, coverage by Pap smear screening in the target group rose from 40% in 1990 to 66% in 1996. The age adjusted cervical cancer mortality rate decreased from 12.8 in 1980 to 6.8 per 100,000 women in 2001.
CONCLUSIONS: Improved organization of the national cervical cancer screening programme in Chile and more efficient use of existing resources resulted in a decrease of cervical cancer mortality.

Entities:  

Mesh:

Year:  2005        PMID: 16188399     DOI: 10.1016/j.cdp.2005.07.001

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  10 in total

1.  Health insurance and cervical cancer screening among older women in Latin American and Caribbean cities.

Authors:  Carlos A Reyes-Ortiz; Luis F Velez; Maria E Camacho; Kenneth J Ottenbacher; Kyriakos S Markides
Journal:  Int J Epidemiol       Date:  2008-05-29       Impact factor: 7.196

2.  Socioeconomic determinants of cervical cancer screening in Latin America.

Authors:  Samir Soneji; Natsu Fukui
Journal:  Rev Panam Salud Publica       Date:  2013-03

3.  Evaluation of a worksite cervical screening initiative to increase Pap smear uptake in Malaysia: a cluster randomized controlled trial.

Authors:  Fauziah Abdullah; Michael O'Rorke; Liam Murray; Tin Tin Su
Journal:  Biomed Res Int       Date:  2013-09-02       Impact factor: 3.411

4.  Perception, attitude and practices of women towards pelvic examination and Pap smear in Jamaica.

Authors:  Paul A Bourne; Christopher A D Charles; Cynthia G Francis; Neva South-Bourne; Racquel Peters
Journal:  N Am J Med Sci       Date:  2010-10

5.  Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.

Authors:  Jorge Alberto Gomez; Alejandro Lepetic; Nadia Demarteau
Journal:  BMC Public Health       Date:  2014-11-26       Impact factor: 3.295

6.  The status of cervical cytology in Swaziland, Southern Africa: a descriptive study.

Authors:  Sylvain Okonda; Colleen Wright; Pam Michelow
Journal:  Cytojournal       Date:  2009-08-06       Impact factor: 2.091

7.  Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa.

Authors:  Cynthia Firnhaber; Nomtha Mayisela; Lu Mao; Sophie Williams; Avril Swarts; Mark Faesen; Simon Levin; Pam Michelow; Tanvier Omar; Michael G Hudgens; Anna-Lise Williamson; Bruce Allan; David A Lewis; Jennifer S Smith
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

8.  Determinants of acceptance of cervical cancer screening in Dar es Salaam, Tanzania.

Authors:  Crispin Kahesa; Susanne Kjaer; Julius Mwaiselage; Twalib Ngoma; Britt Tersbol; Myassa Dartell; Vibeke Rasch
Journal:  BMC Public Health       Date:  2012-12-19       Impact factor: 3.295

9.  Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program.

Authors:  Ebru Tekinturhan; Etienne Audureau; Marie-Pierre Tavolacci; Patricia Garcia-Gonzalez; Joël Ladner; Joseph Saba
Journal:  BMC Health Serv Res       Date:  2013-08-10       Impact factor: 2.655

Review 10.  A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression.

Authors:  Rhafaela Lima Causin; Ana Julia Aguiar de Freitas; Cassio Murilo Trovo Hidalgo Filho; Ricardo Dos Reis; Rui Manuel Reis; Márcia Maria Chiquitelli Marques
Journal:  Cells       Date:  2021-03-17       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.